search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Decontamination chemistry


From chemistry to control


Eric T. Johnson believes it is time to rethink decontamination systems in healthcare. In this article, he argues that there is a need for the decontamination sector to move from reactive chemistry to controlled oxidation.


Healthcare decontamination sits at the intersection of patient safety, workforce protection, operational efficiency, and regulatory accountability. Across operating theatres, endoscopy units, sterile services departments, and critical care environments, the expectations placed on decontamination systems continue to escalate. At the same time, those systems are under increasing strain from throughput pressures, complex device designs, evolving pathogens, and heightened scrutiny around chemical exposure and environmental impact.1,2 Historically, innovation in this space has focused on incremental improvements to disinfectant formulations or procedural refinements. Yet many of the persistent challenges faced by sterile services are not rooted in a lack of effective chemistries, but rather in how those chemistries are generated, delivered, controlled, and integrated into clinical workflows. Bulk preparation, storage instability, inconsistent dosing, and safety trade-offs remain common constraints across widely used approaches.3 This paper argues that the next phase of


progress in decontamination will be driven less by new molecules and more by system-level control of known, effective chemistries at the point of use. By reframing decontamination as a managed process rather than a static product, it becomes possible to address long-standing limitations in safety, consistency, and efficiency. Through this lens, this paper examines the top challenges facing sterile services today and explores how controlled, on-demand decontamination systems may offer a practical path forward.


Challenges facing sterile services Across operating theatres, endoscopy units, and central sterile services departments, several challenges recur consistently: 1. Biofilm persistence: Biofilms within lumened and complex devices remain one of the most significant contributors to reprocessing failure.


Pushing decontamination forward with on-demand oxidisers


Once established, biofilms can resist both mechanical cleaning and chemical disinfection, increasing the risk of cross-contamination and device-associated infections.4 2. Chemical instability and degradation: Many commonly used oxidising agents degrade rapidly once prepared, losing efficacy during storage, transport, or extended use. This can result in variability between intended and delivered concentrations at the point of use.5 3. Workforce safety and training burden: Handling concentrated disinfectants often requires strict controls, personal protective equipment, and specialised training. In understaffed environments, this adds cognitive and operational load to already stretched teams.6 4. Throughput limitations: Reprocessing bottlenecks, particularly in endoscopy and high-volume surgical environments, can delay procedures and reduce overall capacity.


66 www.clinicalservicesjournal.com I November 2026


Chemical contact times, preparation delays, and rework all contribute.5 5. Lack of system-level integration: Decontamination is often treated as a downstream function rather than an integrated component of clinical operations. This limits opportunities for optimisation across departments and facilities.1,5


Addressing these


challenges requires more than substituting one disinfectant for another. It requires reconsidering how chemistry itself is delivered into the system.


Endoscope decontamination and the biofilm problem Endoscopes and other flexible devices represent a particularly challenging use case. Their internal channels, varied materials, and frequent handling make them susceptible to organic residue accumulation, microbial colonisation and biofilm production.4,7


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71